Guardant Health

company

About

Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs in oncology.

Details

Last Funding Type
Series B
Last Funding Money Raised
$30M
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2012
Number Of Employee
501 - 1000
Operating Status
Active
Stock Symbol
nasdaq:GH
Legal Name
Guardant Health, Inc.

Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
9
$787.50M
Guardant Health has raised a total of $787.50M in funding over 2 rounds. Their latest funding was raised on Oct 4, 2018 from a IPO round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 4, 2018 IPO $237.50M Detail
Aug 6, 2018 Series Unknown 1 Detail
Jul 16, 2018 Secondary Market 2 Detail
May 11, 2017 Series E $360M 9 SoftBank Vision Fund Detail
Jan 7, 2016 Series D $100M 10 OrbiMed Detail

Investments

Number of Investments
Number of Lead Investments
1
1
Guardant Health has made 1 investments. Their most recent investment was on Jul 19, 2021, when Lunit raised $26M.
Date Company Name
Round Money Raised Industry Lead Investor
Jul 19, 2021 Lunit
Series C $26M Artificial Intelligence Yes

Investors

Number of Lead Investors
Number of Investors
4
26
Guardant Health is funded by 26 investors. SoftBank Vision Fund and Plug and Play are the most recent investors.
Investor Name Lead Investor Funding Round
SoftBank Vision Fund Yes Series E
Plug and Play Series Unknown
EquityZen Secondary Market
Storm Global Secondary Market
Sequoia Capital Series E
8VC Series E
C.M. Capital Advisors Series E
Khosla Ventures Series E
Lightspeed Venture Partners Series E
OrbiMed Series E

Employee Profiles

Number of Employee Profiles
42
Guardant Health has 42 current employee profiles, including Executive Stephen Swanick
Executive
Advisor
Executive
Executive

Acquisition

Guardant Health has acquired 1 organizations. Their most recent acquisition was Bellwether Bio on Mar 28, 2019. They acquired Bellwether Bio for 0.

Date Company Name
Industry Acquisition Type Price
Mar 28, 2019 Bellwether Bio
Biotechnology acquisition Detail